Ironwood Pharmaceuticals (IRWD) Earnings
|
Expand Research on IRWD
| Next EPS Date | 8/6/26 | EPS Growth Rate | +171.4% |
|---|---|---|---|
| Average EPS % Beat Rate | +90.3% | Revenue Growth Rate | +39.3% |
| Average % Move 1-Wk after EPS | +8.9% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/6/26  |
Q226 | N/A | $0.38 | N/A | N/A | $118.71M | = | N/A | N/A | ||
| 4/30/26 |
Q126 | N/A | $0.19 | N/A | N/A | $92.11M | = | N/A | N/A | ||
| 5/7/26 | Q126 | $0.24 | $0.19 | +$0.05 | $106.51M | $92.11M | = |  | | Details | |
| 5/1/26 |
Q126 | N/A | $0.19 | N/A | N/A | $92.11M | = | N/A | N/A | ||
| 5/4/26 |
Q126 | N/A | $0.19 | N/A | N/A | $92.11M | = | N/A | N/A | ||
| 2/25/26 | Q425 | -$0.01 | $0.02 | -$0.03 | $47.71M | $62.43M | = | | | Details | |
| 2/18/26 |
Q425 | N/A | $0.02 | N/A | N/A | $62.43M | = | N/A | N/A | ||
| 2/17/26 |
Q425 | N/A | $0.02 | N/A | N/A | $62.43M | = | N/A | N/A |
